Biotech Values

[vinmantoo]

Regulus to be acquired by Novartis for $7.00 per share in cash

Novartis to acquire Regulus for $7.00 per share in cash, with potential to receive an additional $7.00 per share in cash through a contingent value right, for a total equity value of up to approximately $1.7 billion

Thanks jbog. You mentioned RGLS as your lottery ticket last year and after looking into it I bought in with my price average at $1.68/share. Not quite the lottery ticket for me but a nice chunk of change. RGLS dropped to $0.97/share at the end of January and I thought about buying more but hesitated and it rebounded quickly so missed out. Anyway, thanks again.